Final report of the phase I / II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients - Mittendorf, E A; Clifton, G T; Holmes, J P (Ann Oncol, 2014)
et al.